11月25日，钱江生化涨5.08%，截至发稿，报6.41元/股，成交5530.66万元，换手率2.84%，总市值55.55 亿元。 从基金十大重仓股角度 责任编辑：小浪快报 民生加银国证2000指数增强A（019814）基金经理为何江。 截至发稿，何江累计任职时间14年189天，现任基金资产总规模8.64亿元，任职期间最佳基金回报 57.31%， 任职期间最差基金回报-49.3%。 资料显示，浙江钱江生物化学股份有限公司位于浙江省海宁市海洲街道钱江西路178号钱江大厦，成立 日期1993年10月28日，上市日期1997年4月8日，公司主营业务涉及环保综合治理、生物制造及热电业 务。从事的主要业务包括环保工程业务、固废医废危废处置业务、污水处理业务及自来水制水业务。从 事植物生长调节剂、杀虫剂、杀菌剂为主的生物农药产品的研发、生产和销售。从事发电供热业务。主 营业务收入构成为：污水处理29.75%，工程施工21.08%，废弃物清运及处置19.04%，生物制品 18.06%，自来水供应6.70%，热电供应4.51%，其他(补充)0.49%，其他0.38%。 风险提示：市场有风险，投资需谨慎。本文为AI大模型自动发 ...

证券日报网讯11月17日晚间，钱江生化（600796）发布公告称，浙江钱江生物化学股份有限公司(以下 简称"公司")分别于2025年10月15日、2025年10月31日召开十届董事会2025年第六次临时会议和2025年 第四次临时股东大会，审议通过了《关于增加经营范围、取消监事会并修订 <公司章程> 的议案》。近 日，公司已办理完成了工商变更登记手续，并取得了浙江省市场监督管理局换发的《营业执照》。 ...

证券代码：600796 股票简称：钱江生化 编号：临 2025—055 法定代表人：朱燕刚 注册资本：捌亿陆仟陆佰伍拾捌万伍仟柒佰陆拾陆元 成立日期：1993 年 10 月 28 日 浙江钱江生物化学股份有限公司 关于完成工商变更登记并换发营业执照的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 浙江钱江生物化学股份有限公司（以下简称"公司"）分别于 2025 年 10 月 15 日、2025 年 10 月 31 日召开十届董事会 2025 年第六次临时会议和 2025 年 第四次临时股东大会，审议通过了《关于增加经营范围、取消监事会并修订<公 司章程>的议案》, 具体内容详见公司在上海证券交易所网站（www.sse.com.cn） 披露的临 2025-049 号公告。 近日，公司已办理完成了工商变更登记手续，并取得了浙江省市场监督管理 局换发的《营业执照》，变更后营业执照具体内容如下： 公司名称：浙江钱江生物化学股份有限公司 统一社会信用代码：913300001429396622 类型：其他股份有限公司（上市） ...

Core Viewpoint - Qianjiang Biochemical (600796) has confirmed the operational status of its solar power projects and is planning additional projects in the renewable energy sector [1] Group 1: Solar Power Projects - The company has successfully completed and put into operation the 3.5MWp solar power project under Changhe Waterworks [1] - The Hongcheng Environmental 1.2MWp solar power project has also been completed and is operational [1] - A new 0.8MWp solar power project associated with the relocation of the Hangzhou Bay New Area sewage treatment plant is expected to be completed by the end of the year [1] - Other solar power projects within the company are still under planning and evaluation [1]

Group 1 - The company Qianjiang Biochemical (600796.SH) has announced the completion and operation of its 1.2MWp photovoltaic project under Hongcheng Environmental Protection, in addition to the 3.5MWp project at Changhe Waterworks [1] - The 3.5MWp distributed photovoltaic project at Changhe Waterworks is expected to generate an annual output of 4 million kWh, saving over 10 million yuan in electricity costs over a 20-year period [3] - The company is planning additional photovoltaic projects, with a 0.8MWp project at the Hangzhou Bay New Area sewage treatment plant expected to be completed by the end of the year [1]

Core Viewpoint - Qianjiang Biochemical (600796.SH) has successfully launched multiple photovoltaic power generation projects, contributing to cost savings and environmental sustainability [1] Group 1: Project Developments - The Changhe Water Affairs 3.5MWp photovoltaic power generation project was completed and operational in March this year [1] - The project has saved 280,000 yuan in electricity costs over four months since its operation [1] - The Hongcheng Environmental 1.2MWp photovoltaic power generation project has also been completed and is operational [1] - An additional 0.8MWp photovoltaic project, associated with the new sewage treatment plant in Hangzhou Bay New Area, is expected to be completed by the end of this year [1]

Core Viewpoint - Qianjiang Biochemical (600796.SH) has successfully launched multiple photovoltaic power generation projects, contributing to cost savings and future project developments [1] Group 1: Project Developments - Changhe Water's 3.5MWp photovoltaic power generation project was completed and operational in March this year, resulting in electricity cost savings of 280,000 yuan over four months [1] - Hongcheng Environmental's 1.2MWp photovoltaic power generation project has also been completed and is now operational [1] - The 0.8MWp photovoltaic project associated with the new sewage treatment plant in Hangzhou Bay New Area is expected to be completed by the end of this year [1]

Core Viewpoint - The company, Zhejiang Qianjiang Biochemical Co., Ltd., is set to hold a third-quarter performance briefing on November 18, 2025, to discuss its operational results and financial status for the third quarter of 2025, allowing investors to engage in a Q&A session [2][3]. Group 1: Meeting Details - The performance briefing will take place on November 18, 2025, from 10:00 to 11:00 AM [4]. - The meeting will be held at the Shanghai Stock Exchange Roadshow Center and will be conducted in an interactive online format [4][5]. - Investors can submit questions from November 11 to November 17, 2025, through the Roadshow Center's website or via the company's email [2][5]. Group 2: Participants - Key participants in the briefing will include the Chairman and General Manager Zhu Yangang, Board Secretary Lu Pingyan, Chief Financial Officer Ma Yuezhong, and Independent Director Wang Lida [4]. Group 3: Investor Participation - Investors can participate in the briefing by logging into the Shanghai Stock Exchange Roadshow Center on the scheduled date and time [4][5]. - The company will address commonly asked questions during the session, ensuring transparency and engagement with investors [3][5]. Group 4: Contact Information - For inquiries, investors can contact the Securities Legal Affairs Department via phone or email [5].

浙江钱江生物化学股份有限公司 关于召开 2025 年第三季度业绩说明会的公告 证券代码：600796 证券简称：钱江生化 公告编号：临 2025-054 （一）会议召开时间：2025年11月18日（星期二）10:00-11:00 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： https://roadshow.sseinfo.com/） 会议召开方式：上证路演中心网络互动 投资者可于 2025 年 11 月 11 日 （星期二） 至 11 月 17 日 （星 期一）16:00 前登录上证路演中心网站首页点击"提问预征集"栏目 或通过公司邮箱 qjbioch@600796.com 进行提问。公司将在说明会上 对投资者普遍关注的问题进行回答。 浙江钱江生物化学股份有限公司（以下简称"公司"）已于 2025 年 10 月 28 日发布公司 2025 年第三季度报告，为便于广大投资者更 全面深入地了解公司 2025 年第三季度经营成果、财务状况，公司计 划于 2025 年 11 月 18 日 （星期二） 10:00-1 ...

Core Viewpoint - The company is actively involved in the "Vanguard" and "Leading Goose" projects in Zhejiang Province, focusing on the development and application of plant growth-promoting bacteria and related stimulants, which aims to enhance soil improvement and profitability [1] Group 1 - The project aims to develop plant growth-promoting bacteria products for soil improvement, expanding the company's product offerings into the soil enhancement sector [1] - The company has completed the development of a high-concentration gibberellic acid soluble agent and one microbial agent, with samples delivered [1] - The microbial fertilizer has entered the registration process, with an expected registration certificate by 2026 [1]